CHRISTOPHER M. STARR

Insider Reports History

Location
Wilmette, IL
Signature
/s/ Quan Vu, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by CHRISTOPHER M. STARR:

Company Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Director Common Stock 9,880 $334,141 $33.82 14 Jul 2025 Indirect
Monopar Therapeutics Director Common Stock 5,173 $206,926 $40.00 14 Jul 2025 Direct
Monopar Therapeutics Director Stock Options 2,924 02 Dec 2025 Direct

Insider Reports Filed by CHRISTOPHER M. STARR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MNPR Monopar Therapeutics 02 Dec 2025 1 $0 4 Director 08 Dec 2025, 16:50
MNPR Monopar Therapeutics 14 Jul 2025 3 -$671,936 4 Director 16 Jul 2025, 21:03
MNPR Monopar Therapeutics 04 Mar 2025 1 $0 4 Director 07 Mar 2025, 20:14
MNPR Monopar Therapeutics 31 Dec 2023 2 $0 4 Director 03 Jan 2024, 19:37
MNPR Monopar Therapeutics 30 Sep 2023 2 $0 4 Director 03 Oct 2023, 19:35
MNPR Monopar Therapeutics 30 Jun 2023 2 $0 4 Director 03 Jul 2023, 18:46
MNPR Monopar Therapeutics 31 Mar 2023 2 $0 4 Director 04 Apr 2023, 17:21
MNPR Monopar Therapeutics 01 Feb 2023 2 $0 4 Director 03 Feb 2023, 17:43
MNPR Monopar Therapeutics 31 Dec 2022 2 $0 4 Director 03 Jan 2023, 15:08
MNPR Monopar Therapeutics 30 Sep 2022 2 $0 4 Director 03 Oct 2022, 19:57
MNPR Monopar Therapeutics 30 Jun 2022 2 $0 4 Director 01 Jul 2022, 16:06
MNPR Monopar Therapeutics 31 Mar 2022 2 $0 4 Director 01 Apr 2022, 17:02
MNPR Monopar Therapeutics 02 Feb 2022 2 $0 4 Director 04 Feb 2022, 18:35
MNPR Monopar Therapeutics 31 Dec 2021 2 $0 4 Director 04 Jan 2022, 12:20
MNPR Monopar Therapeutics 30 Sep 2021 2 $0 4 Director 01 Oct 2021, 19:28
MNPR Monopar Therapeutics 30 Jun 2021 2 $0 4 Director 02 Jul 2021, 17:18